Literature DB >> 11751939

Cutting Edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3'-OH kinase pathway.

Yunji Park1, Seung Woo Lee, Young Chul Sung.   

Abstract

CpG DNA has been recognized as a powerful stimulant of dendritic cells (DCs). In this study, we demonstrate that CpG DNA inhibits spontaneous apoptosis of DCs. CpG DNA up-regulated cellular inhibitor of apoptosis proteins (cIAPs) as well as Bcl-2 and Bcl-x(L), but down-regulated active caspase-3. Although CpG DNA activated p38 mitogen-activated protein kinase, extracellular signal-related kinase, and phosphatidylinositide-3'-OH kinase (PI3K), only the blocking of PI3K inhibited the CpG DNA-induced DC survival. Moreover, while the expression of Bcl-2 and Bcl-x(L) depends on both PI3K and p38 mitogen-activated protein kinase, the up-regulation of cIAPs and the down-regulation of active caspase-3 by CpG DNA require PI3K activation, suggesting PI3K-dependent up-regulation of cIAPs in the antiapoptotic activity of CpG DNA in DCs. This study indicates that CpG DNA provides a survival signal to DCs, which might be one of mechanisms by which bacterial DNA stimulates and maintains the innate immune responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751939     DOI: 10.4049/jimmunol.168.1.5

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  Regulation of antigen uptake, migration, and lifespan of dendritic cell by Toll-like receptors.

Authors:  Ivan Zanoni; Francesca Granucci
Journal:  J Mol Med (Berl)       Date:  2010-06-18       Impact factor: 4.599

2.  Survival adjustment of mature dendritic cells by IL-15.

Authors:  Sigrid P Dubois; Thomas A Waldmann; Jürgen R Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

Review 3.  New players in TLR-mediated innate immunity: PI3K and small Rho GTPases.

Authors:  Monica Ruse; Ulla G Knaus
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  Death receptor signal transducers: nodes of coordination in immune signaling networks.

Authors:  Nicholas S Wilson; Vishva Dixit; Avi Ashkenazi
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

5.  Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg.

Authors:  Rahul Kushwah; Jing Wu; Jordan R Oliver; George Jiang; Jinyi Zhang; Katherine A Siminovitch; Jim Hu
Journal:  Eur J Immunol       Date:  2010-04       Impact factor: 5.532

6.  Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy.

Authors:  Jungsun Park; Haiyan Li; Mingjun Zhang; Yong Lu; Bangxing Hong; Yuhuan Zheng; Jin He; Jing Yang; Jianfei Qian; Qing Yi
Journal:  Cancer Immunol Immunother       Date:  2014-05-20       Impact factor: 6.968

7.  Inhibition of SIRPα in dendritic cells potentiates potent antitumor immunity.

Authors:  Qiong Liu; Wen Wen; Liang Tang; Chen-Jie Qin; Yan Lin; Hui-Lu Zhang; Han Wu; Charles Ashton; Hong-Ping Wu; Jin Ding; Wei Dong; Le-Xing Yu; Wen Yang; Dan-Dan Huang; Meng-Chao Wu; Hong-Yang Wang; He-Xin Yan
Journal:  Oncoimmunology       Date:  2016-08-23       Impact factor: 8.110

8.  4-1BB functions as a survival factor in dendritic cells.

Authors:  Beom K Choi; Young H Kim; Patrick M Kwon; Sang C Lee; Sang W Kang; Moon S Kim; Myoung J Lee; Byoung S Kwon
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 9.  Dendritic cell-based human immunodeficiency virus vaccine.

Authors:  C R Rinaldo
Journal:  J Intern Med       Date:  2009-01       Impact factor: 8.989

10.  The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling.

Authors:  Ming Gao; Tuanzhu Ha; Xia Zhang; Xiaohui Wang; Li Liu; John Kalbfleisch; Krishna Singh; David Williams; Chuanfu Li
Journal:  J Infect Dis       Date:  2013-01-28       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.